13F HOLDINGS REPORT
Casdin Capital, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0000919574-23-003310
Total Value
$1.21B
Positions
41
Other Managers
0
Confidential Omitted
No
Holdings (41)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BIOLIFE SOLUTIONS INC | BLFS | 7,571,535 | $164.7M | 13.57% |
| 2 | SAREPTA THERAPEUTICS INC | SRPT | 1,160,000 | $159.9M | 13.17% |
| 3 | RELAY THERAPEUTICS INC | RLAY | 5,698,574 | $93.9M | 7.73% |
| 4 | EQRX INC | 26886C107 | 39,527,669 | $76.7M | 6.32% |
| 5 | ILLUMINA INC | ILMN | 275,000 | $64.0M | 5.27% |
| 6 | ALNYLAM PHARMACEUTICALS INC | ALNY | 270,000 | $54.1M | 4.46% |
| 7 | INTELLIA THERAPEUTICS INC | NTLA | 1,275,000 | $47.5M | 3.91% |
| 8 | PLIANT THERAPEUTICS INC | PLRX | 1,675,000 | $44.6M | 3.67% |
| 9 | REVOLUTION MEDICINES INC | RVMDW | 1,810,000 | $39.2M | 3.23% |
| 10 | EXACT SCIENCES CORP | 30063P105 | 565,000 | $38.3M | 3.16% |
| 11 | GENEDX HOLDINGS CORP | 81663L101 | 102,151,785 | $37.3M | 3.07% |
| 12 | SOMALOGIC INC | 83444K105 | 12,604,275 | $32.1M | 2.65% |
| 13 | VERVE THERAPEUTICS INC | 92539P101 | 2,120,571 | $30.6M | 2.52% |
| 14 | BLUEPRINT MEDICINES CORP | 09627Y109 | 670,000 | $30.1M | 2.48% |
| 15 | DENALI THERAPEUTICS INC | DNLI | 1,300,000 | $30.0M | 2.47% |
| 16 | MAXCYTE INC | MXCT | 4,925,000 | $24.4M | 2.01% |
| 17 | 2SEVENTY BIO INC | 901384107 | 2,023,913 | $20.6M | 1.70% |
| 18 | ABCELLERA BIOLOGICS INC | ABCL | 2,520,000 | $19.0M | 1.57% |
| 19 | MIRATI THERAPEUTICS INC | 60468T105 | 510,000 | $19.0M | 1.56% |
| 20 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 1,070,000 | $18.4M | 1.52% |
| 21 | BEAM THERAPEUTICS INC | BEAM | 570,000 | $17.5M | 1.44% |
| 22 | TENAYA THERAPEUTICS INC | TNYA | 6,078,860 | $17.3M | 1.43% |
| 23 | STRUCTURE THERAPEUTICS INC | GPCR | 677,017 | $16.1M | 1.33% |
| 24 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 150,000 | $16.1M | 1.33% |
| 25 | AVIDITY BIOSCIENCES INC | 05370A108 | 850,000 | $13.0M | 1.07% |
| 26 | FATE THERAPEUTICS INC | FATE | 2,050,000 | $11.7M | 0.96% |
| 27 | CENTURY THERAPEUTICS INC | IPSC | 3,206,380 | $11.1M | 0.92% |
| 28 | TWIST BIOSCIENCE CORP | TWST | 700,000 | $10.6M | 0.87% |
| 29 | ABSCI CORPORATION | ABSI | 5,393,260 | $9.4M | 0.78% |
| 30 | PRIME MEDICINE INC | PRME | 734,350 | $9.0M | 0.74% |
| 31 | DICE THERAPEUTICS INC | 23345J104 | 310,000 | $8.9M | 0.73% |
| 32 | OPTIMIZERX CORP | OPRX | 500,000 | $7.3M | 0.60% |
| 33 | INCYTE CORP | INCY | 77,500 | $5.6M | 0.46% |
| 34 | MONTE ROSA THERAPEUTICS INC | GLUE | 510,882 | $4.0M | 0.33% |
| 35 | TANGO THERAPEUTICS INC | TNGX | 1,000,000 | $4.0M | 0.33% |
| 36 | SAREPTA THERAPEUTICS INC | SRPT | 25,000 | $3.4M | 0.28% |
| 37 | SINGULAR GENOMICS SYSTEMS IN | 82933R100 | 1,345,722 | $1.6M | 0.13% |
| 38 | INVITAE CORP | 46185L103 | 1,038,388 | $1.4M | 0.12% |
| 39 | EXSCIENTIA PLC | 30223G102 | 213,900 | $1.1M | 0.09% |
| 40 | LIANBIO | LIANY | 206,415 | $402,509 | 0.03% |
| 41 | KRONOS BIO INC | 50107A104 | 123,839 | $180,805 | 0.01% |